SeaStar Medical Holding Corp expected to post a loss of 97 cents a share - Earnings Preview
SeaStar Medical Holding Corp expected to post a loss of 97 cents a share - Earnings Preview
SeaStar Medical Holding Corp ICU.OQ ICU.O is expected to show a rise in quarterly revenue when it reports results on August 12 for the period ending June 30 2026
The Denver Colorado-based company is expected to report a 43.9% increase in revenue to $486.5 thousand from $338 thousand a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for SeaStar Medical Holding Corp is for a loss of 97 cents per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for SeaStar Medical Holding Corp is $10.00, about 227.9% above its last closing price of $3.05
This summary was machine generated August 7 at 13:59 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on SeaStar Medical Holding
See all newsBrief: FDA Grants Seastar Medical Breakthrough Device Designation For Its Scd Therapy For The Treatment Of Hyperinflammation In Adult Patients With Sepsis Or A Septic Condition
SeaStar Medical Holding Corp reports results for the quarter ended June 30 - Earnings Summary
SeaStar Medical Q2 revenue jumps 82% on QUELIMMUNE demand
Brief: SeaStar Medical Q2 EPS USD -0.91
SeaStar Medical Holding Corp expected to post a loss of 97 cents a share - Earnings Preview